{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:00:03Z","timestamp":1778572803814,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Research Council of Shiraz University of Medical Sciences","award":["12852"],"award-info":[{"award-number":["12852"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.imlet.2019.01.010","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T06:55:09Z","timestamp":1548831309000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31"],"prefix":"10.1016","volume":"207","author":[{"given":"M.","family":"Abkar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Alamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Sattarahmady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.imlet.2019.01.010_bib0005","first-page":"381","article-title":"Vaccines in veterinary medicine: a brief review of history and technology","volume":"40","author":"McVey","year":"2010","journal-title":"Vet. Clin.: Small Anim. Pract."},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0010","first-page":"21","article-title":"Brucellosis: past, present and future","volume":"31","author":"Nicoletti","year":"2010","journal-title":"Prilozi"},{"key":"10.1016\/j.imlet.2019.01.010_bib0015","series-title":"Brucella and bioterrorism, Microorganisms and Bioterrorism","first-page":"139","author":"Valderas","year":"2006"},{"issue":"25","key":"10.1016\/j.imlet.2019.01.010_bib0020","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","article-title":"Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51","volume":"22","author":"Ashford","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imlet.2019.01.010_bib0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1574-6976.2010.00211.x","article-title":"Towards a Brucella vaccine for humans","volume":"34","author":"Perkins","year":"2010","journal-title":"FEMS Microbiol. Rev."},{"issue":"12","key":"10.1016\/j.imlet.2019.01.010_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ijpara.2014.07.010","article-title":"Genome-based vaccine design: the promise for malaria and other infectious diseases","volume":"44","author":"Doolan","year":"2014","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.imlet.2019.01.010_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: a review of traditional methods and modern biotechnology approaches","author":"Jorge","year":"2017","journal-title":"Biotechnol. Res. Innov."},{"issue":"4","key":"10.1016\/j.imlet.2019.01.010_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants\u2013current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"J. Saudi Pharm. Soc."},{"key":"10.1016\/j.imlet.2019.01.010_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jconrel.2014.06.027","article-title":"Designing and building the next generation of improved vaccine adjuvants","volume":"190","author":"Brito","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.imlet.2019.01.010_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ab.2015.12.018","article-title":"Nanostructured materials in electroanalysis of pharmaceuticals","volume":"497","author":"Rahi","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.imlet.2019.01.010_bib0055","doi-asserted-by":"crossref","first-page":"15596","DOI":"10.1016\/j.ceramint.2018.05.224","article-title":"Rectangular shaped zinc oxide nanoparticles: green synthesis by Stevia and its biomedical efficiency","volume":"44","author":"Khatami","year":"2018","journal-title":"Ceram. Int."},{"key":"10.1016\/j.imlet.2019.01.010_bib0060","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.msec.2016.02.068","article-title":"Non-enzymatic glucose biosensor based on hyperbranched pine-like gold nanostructure","volume":"63","author":"Heli","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.imlet.2019.01.010_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1872210511666170911153428","article-title":"Applications of nanoflowers in biomedicine","volume":"12","author":"Negahdary","year":"2018","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.imlet.2019.01.010_bib0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.biopha.2017.01.102","article-title":"In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin","volume":"88","author":"Nazari-Vanani","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.imlet.2019.01.010_bib0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijpharm.2017.08.102","article-title":"Erlotinib-loaded albumin nanoparticles: a novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell lines","volume":"531","author":"Noorani","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.imlet.2019.01.010_bib0080","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2381-x","article-title":"Preparation of modified konjac glucomannan nanoparticles and their application as vaccine adjuvants to promote ovalbumin-induced immune response in mice","volume":"35","author":"Chen","year":"2018","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.imlet.2019.01.010_bib0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajps.2014.06.002","article-title":"Nanotechnology and vaccine development","volume":"9","author":"Kim","year":"2014","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.imlet.2019.01.010_bib0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.copbio.2018.03.003","article-title":"Bionanotechnology for vaccine design","volume":"52","author":"Frey","year":"2018","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12250-014-3379-0","article-title":"Calcium phosphate nanoparticles show an effective activation of the innate immune response in vitro and in vivo after functionalization with flagellin","volume":"29","author":"Kozlova","year":"2014","journal-title":"Virol. Sin."},{"issue":"9","key":"10.1016\/j.imlet.2019.01.010_bib0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14760584.2017.1355733","article-title":"Calcium phosphate nanoparticles as a new generation vaccine adjuvant","volume":"16","author":"Lin","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"7","key":"10.1016\/j.imlet.2019.01.010_bib0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/21691401.2016.1233111","article-title":"Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis","volume":"45","author":"Amini","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.imlet.2019.01.010_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in \u2009aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.imlet.2019.01.010_bib0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2013.10.032","article-title":"Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles","volume":"173","author":"Li","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.imlet.2019.01.010_bib0120","article-title":"Chitosan nanoparticle delivery of Influenza A Virus DNA vaccine enhances antibody class switching and abrogates weight loss post IAV challenge","author":"Brown","year":"2017","journal-title":"Am. Assoc. Immnol."},{"key":"10.1016\/j.imlet.2019.01.010_bib0125","first-page":"1","article-title":"Chitosan nanoparticles preparation and applications","author":"Divya","year":"2017","journal-title":"Environ. Chem. Lett."},{"issue":"12","key":"10.1016\/j.imlet.2019.01.010_bib0130","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0135","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1166\/jbn.2013.1545","article-title":"Calcium phosphate nanoparticles for transcutaneous vaccine delivery","volume":"9","author":"Sahdev","year":"2013","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.imlet.2019.01.010_bib0140","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2009.05.011","article-title":"Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination","volume":"138","author":"Slutter","year":"2009","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.imlet.2019.01.010_bib0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/apm.12400","article-title":"Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections","volume":"123","author":"Abkar","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.imlet.2019.01.010_bib0150","first-page":"239","article-title":"Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development","volume":"8","author":"Neto","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2019.01.010_bib0155","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1128\/IAI.00761-12","article-title":"Crucial role of gamma interferon-producing CD4+ Th1 cells but dispensable function of CD8+ T cell, B cell, Th2, and Th17 responses in the control of Brucella melitensis infection in mice","volume":"80","author":"Vitry","year":"2012","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.imlet.2019.01.010_bib0160","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s12257-016-0326-y","article-title":"TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulates strong cellular immunity in mice","volume":"21","author":"Amini","year":"2016","journal-title":"Biotechnol. Bioprocess Eng."},{"issue":"6","key":"10.1016\/j.imlet.2019.01.010_bib0165","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/CDLI.7.6.899-903.2000","article-title":"Calcium phosphate nanoparticle adjuvant","volume":"7","author":"He","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro-and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.imlet.2019.01.010_bib0175","doi-asserted-by":"crossref","first-page":"8769","DOI":"10.2147\/IJN.S149774","article-title":"Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection","volume":"12","author":"Abkar","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.imlet.2019.01.010_bib0180","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S0264-410X(02)00166-4","article-title":"Aluminum salts in vaccines\u2014US perspective","volume":"20","author":"Baylor","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2019.01.010_bib0185","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0264-410X(02)00168-8","article-title":"The global impact of vaccines containing aluminium adjuvants","volume":"20","author":"Clements","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.imlet.2019.01.010_bib0190","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.immuni.2011.03.019","article-title":"Silica crystals and aluminum salts regulate the production of prostaglandin in macrophages via NALP3 inflammasome-independent mechanisms","volume":"34","author":"Kuroda","year":"2011","journal-title":"Immunity"},{"issue":"12-13","key":"10.1016\/j.imlet.2019.01.010_bib0195","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0264-410X(97)00054-6","article-title":"Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties","volume":"15","author":"Goto","year":"1997","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.imlet.2019.01.010_bib0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/14760584.2017.1244484","article-title":"Calcium phosphate: a substitute for aluminum adjuvants?","volume":"16","author":"Masson","year":"2017","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1556-276X-6-67","article-title":"Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers","volume":"6","author":"Chen","year":"2011","journal-title":"Nanoscale Res. Lett."},{"issue":"1","key":"10.1016\/j.imlet.2019.01.010_bib0210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1637\/10510-020413-Reg.1","article-title":"Adjuvant effects of chitosan and calcium phosphate particles in an inactivated Newcastle disease vaccine","volume":"58","author":"Volkova","year":"2013","journal-title":"Avian Dis."},{"key":"10.1016\/j.imlet.2019.01.010_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2018.03.004","article-title":"Intraperitoneal immunization with Urease loaded N-trimethyl Chitosan nanoparticles elicits high protection against Brucella melitensis and Brucella abortus infections","author":"Abkar","year":"2018","journal-title":"Immunol. Lett."},{"issue":"1-2","key":"10.1016\/j.imlet.2019.01.010_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2003.10.038","article-title":"Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge","volume":"275","author":"Kohli","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.imlet.2019.01.010_bib0225","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1021\/nn3057005","article-title":"Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses in vitro and in vivo","volume":"7","author":"Niikura","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.imlet.2019.01.010_bib0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2015.09.069","article-title":"Shape and size-dependent immune response to antigen-carrying nanoparticles","volume":"220","author":"Kumar","year":"2015","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.imlet.2019.01.010_bib0235","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2019.01.010_bib0240","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"9","key":"10.1016\/j.imlet.2019.01.010_bib0245","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1177\/1535370216643771","article-title":"Micro-and nanoparticulates for DNA vaccine delivery","volume":"241","author":"Farris","year":"2016","journal-title":"Exp. Biol. Med."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781830422X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524781830422X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T07:04:13Z","timestamp":1606287853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524781830422X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":49,"alternative-id":["S016524781830422X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.01.010","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}